View Item 

Show simple item record

Capillary Proliferation in Systemicâ Sclerosisâ Related Pulmonary Fibrosis: Association with Pulmonary Hypertension
dc.contributor.authorSeki, Atsuko
dc.contributor.authorAnklesaria, Zafia
dc.contributor.authorSaggar, Rajeev
dc.contributor.authorDodson, Mark W.
dc.contributor.authorSchwab, Kristin
dc.contributor.authorLiu, Ming‐chang
dc.contributor.authorCharan Ashana, Deepshikha
dc.contributor.authorMiller, William D.
dc.contributor.authorVangala, Sitaram
dc.contributor.authorDerHovanessian, Ariss
dc.contributor.authorChannick, Richard
dc.contributor.authorShaikh, Faisal
dc.contributor.authorBelperio, John A.
dc.contributor.authorWeigt, Stephen S.
dc.contributor.authorLynch, Joseph P.
dc.contributor.authorRoss, David J.
dc.contributor.authorSullivan, Lauren
dc.contributor.authorKhanna, Dinesh
dc.contributor.authorShapiro, Shelley S.
dc.contributor.authorSager, Jeffrey
dc.contributor.authorGargani, Luna
dc.contributor.authorStanziola, Anna
dc.contributor.authorBossone, Eduardo
dc.contributor.authorSchraufnagel, Dean e.
dc.contributor.authorFishbein, Gregory
dc.contributor.authorXu, Haodong
dc.contributor.authorFishbein, Michael C.
dc.contributor.authorWallace, William D.
dc.contributor.authorSaggar, Rajan
dc.date.accessioned2019-04-02T18:10:40Z
dc.date.available2020-05-01T18:03:25Zen
dc.date.issued2019-03
dc.identifier.citationSeki, Atsuko; Anklesaria, Zafia; Saggar, Rajeev; Dodson, Mark W.; Schwab, Kristin; Liu, Ming‐chang ; Charan Ashana, Deepshikha; Miller, William D.; Vangala, Sitaram; DerHovanessian, Ariss; Channick, Richard; Shaikh, Faisal; Belperio, John A.; Weigt, Stephen S.; Lynch, Joseph P.; Ross, David J.; Sullivan, Lauren; Khanna, Dinesh; Shapiro, Shelley S.; Sager, Jeffrey; Gargani, Luna; Stanziola, Anna; Bossone, Eduardo; Schraufnagel, Dean e. ; Fishbein, Gregory; Xu, Haodong; Fishbein, Michael C.; Wallace, William D.; Saggar, Rajan (2019). "Capillary Proliferation in Systemicâ Sclerosisâ Related Pulmonary Fibrosis: Association with Pulmonary Hypertension." ACR Open Rheumatology (1): 26-36.
dc.identifier.issn2578-5745
dc.identifier.issn2578-5745
dc.identifier.urihttps://hdl.handle.net/2027.42/148363
dc.publisherWiley Periodicals, Inc.
dc.titleCapillary Proliferation in Systemicâ Sclerosisâ Related Pulmonary Fibrosis: Association with Pulmonary Hypertension
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/148363/1/acr21003.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/148363/2/acr21003_am.pdf
dc.identifier.doi10.1002/acr2.1003
dc.identifier.sourceACR Open Rheumatology
dc.identifier.citedreferenceVolkmann ER, Saggar R, Khanna D, Torres B, Flora A, Yoder L, et al. Improved transplantâ free survival in patients with systemic sclerosisâ associated pulmonary hypertension and interstitial lung disease. Arthritis Rheumatol 2014; 66: 1900 â 8.
dc.identifier.citedreferenceCondliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue diseaseâ associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179: 151 â 7.
dc.identifier.citedreferencePark JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular diseaseâ related subtypes. Am J Respir Crit Care Med 2007; 175: 705 â 11.
dc.identifier.citedreferenceKim KH, Maldonado F, Ryu JH, Eiken PW, Hartman TE, Bartholmai BJ, et al. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Res 2010; 11: 37.
dc.identifier.citedreferenceVarnholt H, Kradin R. Pulmonary capillary hemangiomatosis arising in hereditary hemorrhagic telangiectasia. Hum Pathol 2004; 35: 266 â 8.
dc.identifier.citedreferenceGüttinger E, Vrugt B, Speich R, Ulrich S, Schwitz F, Arrigo M, et al. Reactive pulmonary capillary hemangiomatosis and pulmonary venoâ occlusive disease in a patient with repaired scimitar syndrome. Case Rep Cardiol 2016; 2016: 9384126.
dc.identifier.citedreferenceLee C, Suh RD, Krishnam MS, Lai CK, Fishbein MC, Wallave WD, et al. Recurrent pulmonary capillary hemangiomatosis after bilateral lung transplantation. J Thorac Imaging 2010; 25: W89 â 92.
dc.identifier.citedreferenceDuBrock HM, Kradin RL, Rodriguezâ Lopez JM, Channick RN. Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing. Pulm Circ 2015; 5: 580 â 6.
dc.identifier.citedreferenceOverbeek MJ, Vonk MC, Boonstra A, Voskuyl AE, Vonkâ Noordegraaf A, Smit EF, et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur Respir J 2009; 34: 371 â 9.
dc.identifier.citedreferenceOdronic SI, Narula T, Budev M, Farver C. Pulmonary capillary hemangiomatosis associated with connective tissue disease: a report of 4 cases and review of the literature. Ann Diagn Pathol 2015; 19: 149 â 53.
dc.identifier.citedreferenceDorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Müller KM, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007; 38: 893 â 902.
dc.identifier.citedreferenceLe Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, et al. Systemic sclerosisâ related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. Arthritis Rheumatol 2011; 63: 2456 â 64.
dc.identifier.citedreferenceTrad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin le TH, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheumatol 2006; 54: 184 â 91.
dc.identifier.citedreferenceRol N, Timmer EM, Faes TJ, Vonk Noordegraaf A, Grünberg K, Bogaard HJ, et al. Vascular narrowing in pulmonary arterial hypertension is heterogeneous: rethinking resistance. Physiol Rep 2017; 5: e13159.
dc.identifier.citedreferenceAiello VD, Thomaz AM, Pozzan G, Lopes AA. Capillary hemangiomatosis likeâ lesions in lung biopsies from children with congenital heart defects. Pediatr Pulmonol 2014; 49: E82 â 5.
dc.identifier.citedreferenceSakashita N, Motooka Y, Suganuma M, Ohnishi K, Fujiwara Y, Nakagawa T, et al. A case of pulmonary capillary hemangiomatosis with pulmonary fibrosis associated with MMPâ 9 related pulmonary remodeling. Pathol Int 2011; 61: 306 â 12.
dc.identifier.citedreferenceTuder RM, Abman SH, Braun T, Capron F, Stevens T, Thistlethwaite PA, et al. Development and pathology of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S3 â 9.
dc.identifier.citedreferenceLantuéjoul S, Sheppard MN, Corrin B, Burke MM, Nicholson AG. Pulmonary venoâ occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 2006; 30: 850 â 7.
dc.identifier.citedreferenceRenzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 2003; 167: 438 â 43.
dc.identifier.citedreferenceSchraufnagel DE, Mehta D, Harshbarger R, Treviranus K, Wang NS. Capillary remodeling in bleomycinâ induced pulmonary fibrosis. Am J Pathol 1986; 125: 97 â 106.
dc.identifier.citedreferenceKeane MP, Arenberg DA, Lynch JP, Whyte RI, Iannettoni MD, Burdick MD, et al. The CXC chemokines, ILâ 8 and IPâ 10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997; 159: 1437 â 43.
dc.identifier.citedreferenceTurnerâ Warwick M. Precapillary systemicâ pulmonary anastomoses. Thorax 1963; 18: 225 â 37.
dc.identifier.citedreferencePencina MJ, D’Agostino RB, Sr. Evaluating discrimination of risk prediction models: the C statistic. JAMA 2015; 314: 1063 â 4.
dc.identifier.citedreferenceMiura A, Nakamura K, Kusano KF, Matsubara H, Ogawa A, Akagi S, et al. Threeâ dimensional structure of pulmonary capillary vessels in patients with pulmonary hypertension. Circulation 2010; 121: 2151 â 3.
dc.identifier.citedreferenceTuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, Michelakis E, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D4 â 12.
dc.identifier.citedreferenceTravis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733 â 48.
dc.identifier.citedreferenceMatsukuma S, Sato K. Pulmonary capillary haemangiomatosisâ like lesions in severely congested lungs. Histopathology 2011; 59: 876 â 81.
dc.identifier.citedreferenceNathan SD, Shlobin OA, Ahmad S, Koch J, Barnett SD, Ad N, et al. Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 2008; 76: 288 â 94.
dc.identifier.citedreferenceWagenvoort CA, Beetstra A, Spijker J. Capillary haemangiomatosis of the lungs. Histopathology 1978; 2: 401 â 6.
dc.identifier.citedreferenceColombat M, Mal H, Groussard O, Capron F, Thabut G, Jebrak G, et al. Pulmonary vascular lesions in endâ stage idiopathic pulmonary fibrosis: histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics. Hum Pathol 2007; 38: 60 â 5.
dc.identifier.citedreferenceEbina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki Y, Endo M, et al. Heterogeneous increase in CD34â positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004; 169: 1203 â 8.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acr21003.pdf
Size:
1.026MB
Format:
PDF
View/Open
Name:
acr21003_am.pdf
Size:
1.263MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.